SCHEMBL12408151

SCHEMBL12408151

CC=C(C=O)N1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
L3MBTL1 Q9Y468 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ATM Q13315 1/20 0.36
HPGD P15428 3/20 0.34
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP9 P14780 1/20 0.34
CA2 P00918 3/20 0.33
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA9 Q16790 2/20 0.33
CHKA P35790 1/20 0.33
F2 P00734 1/20 0.33
MAPT P10636 1/20 0.32
TSHR P16473 1/20 0.32
GFER P55789 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12407887 1.00 ALDH1A1 (0.40) ALDH1A1L3MBTL1MEN1KMT2ATDP1
SCHEMBL12408140 0.97 ATM (0.37) ALDH1A1L3MBTL1MEN1KMT2ATDP1
SCHEMBL14345855 0.80 ALDH1A1 (0.40) ALDH1A1L3MBTL1MEN1KMT2ATDP1
SCHEMBL9251104 0.76 SMN1; SMN2 (0.46) ALDH1A1L3MBTL1MEN1KMT2AMMP1
SCHEMBL9251101 0.76 SMN1; SMN2 (0.46) ALDH1A1L3MBTL1MEN1KMT2AMMP1
SCHEMBL5598157 0.75 ALDH1A1 (0.35) ALDH1A1L3MBTL1MEN1KMT2ATDP1
SCHEMBL28974793 0.73 CA12 (0.46) ALDH1A1MEN1KMT2ACA2CA12
SCHEMBL5598109 0.72 TGM2 (0.32) ALDH1A1L3MBTL1MEN1KMT2ATDP1
SCHEMBL21163723 0.70 ATM (0.31) ALDH1A1L3MBTL1ATMHPGDMAPT
SCHEMBL1475208 0.69 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AHPGDMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107628960-B Method for synthesizing ketene aminal by olefin in one step 华南理工大学 2020-12-22 CN disclosed
US-7989478-B2 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-08-02 US disclosed
US-7691883-B2 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-06 US disclosed
US-20100081652-A1 Cinnamoyl Compound and Use Thereof SHIRAKI HIROAKI 2010-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081652-A1 Cinnamoyl Compound and Use Thereof COL2A1, MMP7, COL14A1 ALDH1A1 474/4885L3MBTL1 3616/4885MEN1 2870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.